BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7903794)

  • 1. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
    Weismanová E; Kalúz S; Skorvaga M
    Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated H-ras oncogenes in human kidney tumors.
    Fujita J; Kraus MH; Onoue H; Srivastava SK; Ebi Y; Kitamura Y; Rhim JS
    Cancer Res; 1988 Sep; 48(18):5251-5. PubMed ID: 2457438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
    Ishikawa J; Maeda S; Kamidono S; Sugiyama T
    Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
    Bouras M; Parvaz P; Berger N; Paulin C; Revol A
    Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma.
    Ogata N; Kamimura T; Asakura H
    Hepatology; 1991 Jan; 13(1):31-7. PubMed ID: 1846346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris].
    Liu XF
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Point mutation of c-Ha-ras oncogene in oral cancers].
    Liu XF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Nov; 26(6):326-8, 388. PubMed ID: 1820236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
    Shan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
    Vachtenheim J; Horáková I; Novotná H
    Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
    Kumar R; Dunn LL
    Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated ras alleles in human carcinoma of the prostate are rare.
    Gumerlock PH; Poonamallee UR; Meyers FJ; deVere White RW
    Cancer Res; 1991 Mar; 51(6):1632-7. PubMed ID: 1998954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation of c-Ha-ras point mutation to the prognosis and metastasis of gastric carcinoma].
    Deng GR
    Zhonghua Yi Xue Za Zhi; 1989 Aug; 69(8):438-42, 32. PubMed ID: 2575929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.